Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat

7680574490020 CH-57449 Fertigspritze
Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
1 / 3
google

Article details

Package size
1 x 1
Selling units
1
Measure
Spritze(n)
Galenic form
Fertigspritze
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/02/2025
Summary of Product Characteristics
Français
15/02/2025
Summary of Product Characteristics
Italien
15/02/2025

Detailed composition

Substance Quantity Type Category
leuprorelinum
3.6 MG Substance Wirkstoff (Principe actif)
leuprorelini acetas
- Substance WIZUS
poly(lactidum-co-glycolidum)
- Substance HNIDK

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
57449
Drug name
Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
Galenic form
IMPF
ATC Code
L02AE02
Authorization status
Revoked/Withdrawn
Dispensing category
A
First authorization
04/06/2008
Authorization expiration date
31/05/2026
IT Number
07.16.2.
Domain
Human medicine
Field of application
Onkologikum / LHRH-Analogon

Package details

Description (FR)
LEUPRORELINE Sandoz 1 mois implant 3.6 mg ser pré
Description (DE)
LEUPRORELIN Sandoz 1 Monat Implant 3.6 mg Fertspr
Market launch
04/06/2008
Market withdrawal
31/05/2026
Narcotic (BTM)
No

Other package sizes (1)

None
3 x 1 SPRI
GTIN: None
Not in V1
Buy us a coffee Explore the data